A Senthil Kumar

  • Citations Per Year
Learn More
BACKGROUND Topical steroids remain the mainstay of treatment in eczema, an inflammatory skin reaction characterized by pruritus, redness, scaling, and clustered oozing papulovesicles. Halometasone is a new potent corticosteroid approved in the Indian market for topical application in the treatment of dermatitis. AIMS To evaluate the efficacy and safety of(More)
OBJECTIVE To evaluate the role of Resistive index measured by cranial doppler ultrasonography in predicting the risk of death/ abnormal neurodevelopmental outcomes in term neonates with hypoxic ischemic encephalopathy. METHODS We enrolled 50 term asphyxiated neonates with hypoxic ischemic encephalopathy and measured resistive index within 72 hours from(More)
Background: Topical steroids remain the mainstay of treatment in eczema, an inflammatory skin reaction characterized by pruritus, redness, scaling, and clustered oozing papulovesicles. Halometasone is a new potent corticosteroid approved in the Indian market for topical application in the treatment of dermatitis. Aims: To evaluate the efficacy and safety of(More)
BACKGROUND Topical antifungal agents along with the steroids may provide not only rapid symptomatic relief but also clearance of disease causing fungi in inflamed cutaneous mycoses (ICM). AIM To assess the efficacy and safety of fixed dose combination (FDC) of Eberconazole nitrate 1% and Mometasone furoate 0.1% w/w cream, in subjects with ICM. METHODS(More)
From the Department of Neonatology, CHILDS Trust Medical Research Foundation and Kanchi Kamakoti CHILDS Trust Hospital, and *Department of Radiology, Kilpauk Medical College; Chennai, Tamil Nadu, India. Correspondence to: Dr Aparna Chandrasekaran, Department of Neonatology, CHILDS Trust Medical Research Foundation and Kanchi Kamakoti CHILDS Trust Hospital,(More)
CONTEXT An epidemic of chikungunya disease occurred in India during late 2005 through 2006 affecting nearly 1,400,000 people. AIM To study the cutaneous manifestations in suspected cases of chikungunya disease. SETTINGS AND DESIGN Patients who attended our outpatient departments from January 2006 to September 2006 were prospectively included if they had(More)
  • 1